MAPT and Alzheimer disease: Therefore, there is an urgent need for systematic and quantitative analyses of retinal pTau in larger cohorts as well as assessment of both the spatiotemporal and pathomechanistic properties of AD-related tau species in the retina and their relationship with brain disease and cognition.